Login to Your Account

‘Peptidream’ come true in $1.15B peptide discovery deal with Janssen

By Marie Powers
News Editor

Friday, April 7, 2017

Following a string of big pharma deals dating back to 2010, Tokyo-based Peptidream Inc. inked a potential $1.15 billion multitarget discovery and optimization collaboration with Janssen Pharmaceuticals Inc. that could be its largest yet.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription